Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma
Yi-Dan Chen,1 Zhong-Yuan Liang,1 Yan-Yan Cen,1 He Zhang,2 Mei-Gui Han,2 Yun-Qiao Tian,2 Jie Zhang,2 Shu-Jun Li,2 and Da-Sheng Yang2
1College of Pharmacy, The Third Military Medical University, Chongqing, People’s Republic of China
2Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, People’s Republic of China
Correspondence: Yan-Yan Cen, College of Pharmacy, The Third Military Medical University, No 30 Gaotanyan Street, Shapingba District, Chongqing 400038, People’s Republic of China, Tel/fax +86 373 440 2514, Email moc.liamtoh@26necnaynay
Drug Des Devel Ther. 2015; 9: 5815–5825.
Published online 2015 Nov 20. doi: 10.2147/DDDT.S86075
1College of Pharmacy, The Third Military Medical University, Chongqing, People’s Republic of China
2Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, People’s Republic of China
Correspondence: Yan-Yan Cen, College of Pharmacy, The Third Military Medical University, No 30 Gaotanyan Street, Shapingba District, Chongqing 400038, People’s Republic of China, Tel/fax +86 373 440 2514, Email moc.liamtoh@26necnaynay
Drug Des Devel Ther. 2015; 9: 5815–5825.
Published online 2015 Nov 20. doi: 10.2147/DDDT.S86075